Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Treatment with SM-164 at 5 mg/kg reduces the tumor volume from 147±54 mm3 at the beginning of the treatment (day 25) to 54±32 mm3 at the end of the treatment (day 36)
Mollugin is a major bioactive component isolated from Rubia cordifolia L
thereby decreasing cardiac output and myocardial oxygen demands
with IC50s of 150 and 10 nM
Anabasine does not have any significant effects on response latency when administered alone
Fibrinogen Binding Inhibitor Peptide prazole Treatment with SM-164 at 5Fibrinogen Binding Inhibitor Peptide is a dodecapeptide (HHLGGAKQAGDV, H12), which is a fibrinogen chain carboxy terminal sequence (400 411). Fibrinogen Binding Inhibitor Peptide is a specific binding site of the ligand for activated glycoprotein (GP) IIb IIIa. Product information CAS Number: 89105 94 2 Molecular Weight: 1189. 28 Formula: C50H80N18O16 Chemical Name: (2S) 2 [(2S) 2 {2 [(2S) 2 [(2S) 2 [(2S) 6 amino 2 [(2S) 2 (2 {2 [(2S) 2 [(2S) 2 [(2S)
US$ 999.50
US$ 186.00
US$ 351.00
US$ 227.00
US$ 675.00
US$ 449.50
US$ 401.50
US$ 1999.50
US$ 1329.50
US$ 401.50
US$ 411.00
US$ 3249.00
US$ 261.50
US$ 1347.00